[ET Net News Agency, 7 November 2023] CLOVER BIO-B (02197) rose 21.1% to HK$0.86,
breaking above the 50-D SMA of HK$0.819.
It hits an intra-day high of HK$0.86, hitting an 1-month high, and an intra-day low of
HK$0.71. The total shares traded was 15.11 million, with a value of HK$12.19m. The active
buy/sell ratio is 73:27, with net buying turnover of HK$5.61m. BNP PARIBAS SEC (ASIA)
accounts for greatest net responsive buying turnover of HK$664,028, with volume weighted
average price of HK$0.799. BOCI SEC accounts for greatest net responsive selling turnover
of HK$1.87m, with volume weighted average price of HK$0.835. The stock has risen a
combined 28.4% over the past 2 consecutive trading days.
Basic Information
=================
----------------------------------
Nominal 0.860 % Chg +21.13%
High 0.860 Low 0.710
Shares Tr 15.11m Turnover 12.19m
10-D SMA 0.676 %H.V 88.310
20-D SMA 0.670 VWAP 0.806
50-D SMA 0.819 RSI14 64.081
----------------------------------
Status: Breaking above the 50-D SMA, hitting an 1-month high, active buy/sell ratio is
73:27, with net buying turnover of HK$5.61m, rising a combined 28.4% over the past 2
consecutive trading days
Performance of stocks in the same sector or of relevance
========================================================
Stock (Code) Price (HK$) Change (%)
---------------------------------------------
CLOVER BIO-B (02197) 0.86 +21.13
HUTCHMED (00013) 31.80 -0.62
GENSCRIPT BIO (01548) 24.35 -0.41
INNOVENT BIO (01801) 48.05 -0.72
EVEREST MED-B (01952) 29.35 +1.73
KEYMED BIO-B (02162) 60.90 -1.22
WUXI BIO (02269) 49.10 -2.00
BEIGENE (06160) 118.70 -3.89
AKESO (09926) 48.15 +2.56
ALPHAMAB-B (09966) 12.60 +5.53
---------------------------------------------
(ed)